Page last updated: 2024-11-01

ondansetron and Bowel Diseases, Inflammatory

ondansetron has been researched along with Bowel Diseases, Inflammatory in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"Primary biliary cirrhosis (PBC), autoimmune cholangitis (AIC = AMA-negative PBC) and primary sclerosing cholangitis (PSC) are autoimmune cholestatic liver diseases."2.42[Cholestatic liver diseases]. ( Blum, HE; Kreisel, W; Opitz, OG; Thimme, R, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gomollón, F1
Rubio, S1
Charro, M1
García-López, S1
Muñoz, F1
Gisbert, JP1
Domènech, E1
Thimme, R1
Opitz, OG1
Blum, HE1
Kreisel, W1

Reviews

1 review available for ondansetron and Bowel Diseases, Inflammatory

ArticleYear
[Cholestatic liver diseases].
    Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8

    Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruriti

2004

Other Studies

1 other study available for ondansetron and Bowel Diseases, Inflammatory

ArticleYear
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:1

    Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Inju

2015